{
    "case_number": "CAC-UDRP-104376",
    "time_of_filling": "2022-02-28 11:20:54",
    "domain_names": [
        "cyltezo.xyz"
    ],
    "case_administrator": "  Iveta Špiclová   (Czech Arbitration Court) (Case admin)",
    "complainant": [
        "Boehringer Ingelheim International GmbH"
    ],
    "complainant_representative": "NAMESHIELD S.A.S.",
    "respondent": [
        "LIUQINGRU"
    ],
    "respondent_representative": null,
    "factual_background": "FACTS ASSERTED BY THE COMPLAINANT AND NOT CONTESTED BY THE RESPONDENT:\r\n\r\nIt results from the Complainant’s undisputed allegations that it is a German family-owned pharmaceutical group of companies founded by Albert Boehringer in 1885. Ever since, it has become a global research-driven pharmaceutical enterprise and one of the top 20 companies in the pharmaceutical industry, with roughly 52,000 employees. The Complainant’s three main business areas are Human Pharma, Animal Health and Biopharmaceutical Contract Manufacturing. In addition, the Complainant’s product CYLTEZO was approved by the U.S. Food and Drug Administration (FDA) in August 2017 for the treatment of multiple chronic inflammatory diseases including rheumatoid arthritis, psoriasis and Crohn’s disease\r\n\r\nMoreover, the Complainant owns the domain name <cyltezo.com> (registered on July 29, 2014).\r\n\r\nThe disputed domain name <cyltezo.xyz> was created on February 21, 2022 and resolved to an inactive webpage.",
    "other_legal_proceedings": "The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.",
    "no_response_filed": "\r\nNO ADMINISTRATIVELY COMPLIANT RESPONSE HAS BEEN FILED.\r\n\r\n",
    "rights": "The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).",
    "no_rights_or_legitimate_interests": "The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).",
    "bad_faith": "The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).",
    "procedural_factors": "The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.",
    "decision": "Accepted",
    "panelists": [
        "Dr. Federica Togo"
    ],
    "date_of_panel_decision": "2022-04-08 00:00:00",
    "informal_english_translation": "The Complainant is the registered owner of several trademark registrations for the term CYLTEZO, e.g. International registration no. 1242575 registered on January 19, 2015 for “Pharmaceutical preparations” in class 5 and designating several countries worldwide amongst others China and European Union.",
    "decision_domains": {
        "CYLTEZO.XYZ": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}